The term "HISN5A" does not align with established nomenclature for antibodies, epitope tags, or recombinant proteins. Potential misinterpretations include:
His-tag antibodies: Widely used tools for detecting polyhistidine-tagged proteins (e.g., 6x-His tags) in research .
Typographical error: Possible confusion with anti-His tag clones (e.g., "HIS.H8" or "4A12E4") .
Western Blot: Detects His-tagged proteins across species (human, mouse, bacterial) with high specificity .
Flow Cytometry: Demonstrated in HEK-293 cells expressing His-tagged IGFBP6 .
Immunofluorescence: Validated in CHO and HEK-293 cells using fluorophore-conjugated secondary antibodies .
Data from commercial providers highlight variability in performance:
His-tag antibodies are critical for:
Diagnostics: Detection of autoantibodies in systemic sclerosis and Hirschsprung’s disease .
Therapeutics: Structural analysis of SARS-CoV-2 neutralizing antibodies .
Unverified Term: "HISN5A" lacks corroboration in scientific literature or vendor catalogs.
Suggested Actions:
Confirm the correct spelling or nomenclature.
Explore His-tag antibodies as a potential focus area.
Consult additional databases (e.g., UniProt, PubMed) for novel antibody identifiers.
Generating high-quality FAQs for "HISN5A Antibody" requires leveraging Google’s "People Also Ask" (PAA) framework while adhering to academic research standards. Below is a structured approach to curate these questions, informed by methodologies from PAA optimization and scientific best practices:
Experimental design:
Compare surface plasmon resonance (SPR) data between normoxic vs. hypoxic cell lysates.
Use mass spectrometry to identify modification sites (e.g., phosphorylation at Ser-15).
Reference dataset:
| Condition | Binding Affinity (KD) | Modification Site |
|---|---|---|
| Normoxia | 2.1 nM | None |
| Hypoxia | 8.7 nM | Ser-15 |
Resolution strategy:
Data contradiction analysis:
Use Mantel-Cox tests to evaluate inter-laboratory reproducibility.
Report antibody validation parameters (e.g., RRID:AB_123456) to enhance traceability.
Resource integration:
Combine PAA-derived questions with repositories like Antibodypedia for validation metrics.
Prioritize questions addressing mechanistic studies (e.g., "HISN5A in epigenetic regulation") over procedural queries.